Paola Rogliani to Animals
This is a "connection" page, showing publications Paola Rogliani has written about Animals.
Connection Strength
0.322
-
Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice? Int Arch Allergy Immunol. 2019; 180(2):142-143.
Score: 0.025
-
Can f 5 as a suitable marker of dog allergy: Assess male dog exposure before banning it. J Allergy Clin Immunol. 2019 04; 143(4):1657-1658.
Score: 0.024
-
Occupational exposure to furry animals and asthma: The complex interconnection between work and everyday life. Ann Allergy Asthma Immunol. 2018 10; 121(4):512-513.
Score: 0.023
-
Safety of humanized monoclonal antibodies against IL-5 in asthma: focus on reslizumab. Expert Opin Drug Saf. 2018 Apr; 17(4):429-435.
Score: 0.022
-
Critical aspects in dog allergen immunotherapy (DAI). May Component Resolved Diagnosis (CRD) play a role in predicting the efficacy? Hum Vaccin Immunother. 2018 06 03; 14(6):1438-1441.
Score: 0.022
-
Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD. Curr Opin Pharmacol. 2018 06; 40:34-38.
Score: 0.022
-
Dog allergy: can a prevalent or exclusive sensitization to Can f 5 be considered a lucky or negative event in real life? Eur Ann Allergy Clin Immunol. 2018 11; 50(6):283-285.
Score: 0.022
-
Anaphylaxis and intimate behaviour. Curr Opin Allergy Clin Immunol. 2017 Oct; 17(5):350-355.
Score: 0.022
-
Is the risk of developing atopic sensitization and bronchial asthma in animal laboratory workers preventable in well-defined susceptible individuals? J Occup Health. 2017 May 25; 59(3):310-311.
Score: 0.021
-
Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience. Eur Ann Allergy Clin Immunol. 2017 03; 49(2):92-96.
Score: 0.021
-
What Could the Role of Can f 5 Allergen Be in Dog-Sensitized Patients in "Real Life"? J Investig Allergol Clin Immunol. 2017; 27(6):397-398.
Score: 0.021
-
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs. 2019 Oct; 28(10):827-833.
Score: 0.006
-
Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics. Trends Pharmacol Sci. 2019 07; 40(7):452-463.
Score: 0.006
-
Allergy in adolescent population (14-18 years) living in Campania region (Southern Italy). A multicenter study. Eur Ann Allergy Clin Immunol. 2019 01; 51(1).
Score: 0.006
-
Emerging antibacterial and antiviral drugs for treating respiratory tract infections. Expert Opin Emerg Drugs. 2018 09; 23(3):185-199.
Score: 0.006
-
Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach? Expert Opin Investig Drugs. 2018 07; 27(7):573-581.
Score: 0.006
-
Combining long-acting bronchodilators with different mechanisms of action: A pharmacological approach to optimize bronchodilation of equine airways. J Vet Pharmacol Ther. 2018 Aug; 41(4):546-554.
Score: 0.006
-
Clinical effect of corticosteroids in asthma-affected horses: A quantitative synthesis. Equine Vet J. 2018 Sep; 50(5):594-601.
Score: 0.006
-
Effect of lipopolysaccharide on the responsiveness of equine bronchial tissue. Pulm Pharmacol Ther. 2018 04; 49:88-94.
Score: 0.006
-
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma. Expert Opin Drug Metab Toxicol. 2018 Feb; 14(2):239-245.
Score: 0.006
-
Benralizumab for the treatment of asthma. Drugs Today (Barc). 2017 Dec; 53(12):633-645.
Score: 0.005
-
Targeting Mechanisms Linking COPD to Type 2 Diabetes Mellitus. Trends Pharmacol Sci. 2017 10; 38(10):940-951.
Score: 0.005
-
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi. COPD. 2017 Oct; 14(5):526-532.
Score: 0.005
-
Bronchodilator therapy for chronic cough. Pulm Pharmacol Ther. 2017 Dec; 47:88-92.
Score: 0.005
-
Pharmacological treatments in asthma-affected horses: A pair-wise and network meta-analysis. Equine Vet J. 2017 Nov; 49(6):710-717.
Score: 0.005